These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38325689)

  • 1. Targeting the PDK/PDH axis to reverse metabolic abnormalities by structure-based virtual screening with in vitro and in vivo experiments.
    Yue J; Xu J; Yin Y; Shu Y; Li Y; Li T; Zou Z; Wang Z; Li F; Zhang M; Liang S; He X; Liu Z; Wang Y
    Int J Biol Macromol; 2024 Mar; 262(Pt 1):129970. PubMed ID: 38325689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Connection of Inflammatory Pain: Pivotal Role of a Pyruvate Dehydrogenase Kinase-Pyruvate Dehydrogenase-Lactic Acid Axis.
    Jha MK; Song GJ; Lee MG; Jeoung NH; Go Y; Harris RA; Park DH; Kook H; Lee IK; Suk K
    J Neurosci; 2015 Oct; 35(42):14353-69. PubMed ID: 26490872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time hyperpolarized
    Sharma G; Wu CY; Wynn RM; Gui W; Malloy CR; Sherry AD; Chuang DT; Khemtong C
    Sci Rep; 2019 Nov; 9(1):16480. PubMed ID: 31712597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis.
    Woolbright BL; Rajendran G; Harris RA; Taylor JA
    Mol Cancer Ther; 2019 Oct; 18(10):1673-1681. PubMed ID: 31511353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCA Protects against Oxidation Injury Attributed to Cerebral Ischemia-Reperfusion by Regulating Glycolysis through PDK2-PDH-Nrf2 Axis.
    Zhao X; Li S; Mo Y; Li R; Huang S; Zhang A; Ni X; Dai Q; Wang J
    Oxid Med Cell Longev; 2021; 2021():5173035. PubMed ID: 34712383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy.
    Anwar S; Shamsi A; Mohammad T; Islam A; Hassan MI
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188568. PubMed ID: 34023419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiamine mimetics sulbutiamine and benfotiamine as a nutraceutical approach to anticancer therapy.
    Jonus HC; Byrnes CC; Kim J; Valle ML; Bartlett MG; Said HM; Zastre JA
    Biomed Pharmacother; 2020 Jan; 121():109648. PubMed ID: 31810115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis to discover potent PDK inhibitors through structure-based virtual screening and pharmacological evaluation.
    Gan L; Yang Y; Liang Z; Zhang M; He Y; Zhang SL
    Eur J Med Chem; 2024 Jan; 264():116008. PubMed ID: 38056298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of PDK mRNA by high fatty acid and glucose in pancreatic islets.
    Xu J; Han J; Epstein PN; Liu YQ
    Biochem Biophys Res Commun; 2006 Jun; 344(3):827-33. PubMed ID: 16631612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial pyruvate dehydrogenase kinases contribute to platelet function and thrombosis in mice by regulating aerobic glycolysis.
    Flora GD; Nayak MK; Ghatge M; Kumskova M; Patel RB; Chauhan AK
    Blood Adv; 2023 Jun; 7(11):2347-2359. PubMed ID: 36971790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells.
    Cesi G; Walbrecq G; Zimmer A; Kreis S; Haan C
    Mol Cancer; 2017 Jun; 16(1):102. PubMed ID: 28595656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate dehydrogenase kinase regulates vascular inflammation in atherosclerosis and increases cardiovascular risk.
    Forteza MJ; Berg M; Edsfeldt A; Sun J; Baumgartner R; Kareinen I; Casagrande FB; Hedin U; Zhang S; Vuckovic I; Dzeja PP; Polyzos KA; Gisterå A; Trauelsen M; Schwartz TW; Dib L; Herrmann J; Monaco C; Matic L; Gonçalves I; Ketelhuth DFJ
    Cardiovasc Res; 2023 Jul; 119(7):1524-1536. PubMed ID: 36866436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease.
    Naia L; Cunha-Oliveira T; Rodrigues J; Rosenstock TR; Oliveira A; Ribeiro M; Carmo C; Oliveira-Sousa SI; Duarte AI; Hayden MR; Rego AC
    J Neurosci; 2017 Mar; 37(10):2776-2794. PubMed ID: 28123081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket.
    Tso SC; Qi X; Gui WJ; Wu CY; Chuang JL; Wernstedt-Asterholm I; Morlock LK; Owens KR; Scherer PE; Williams NS; Tambar UK; Wynn RM; Chuang DT
    J Biol Chem; 2014 Feb; 289(7):4432-43. PubMed ID: 24356970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic reorganization in winter: Regulation of pyruvate dehydrogenase (PDH) during long-term freezing and anoxia.
    Al-Attar R; Wijenayake S; Storey KB
    Cryobiology; 2019 Feb; 86():10-18. PubMed ID: 30639451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer.
    Nunes-Xavier CE; Mingo J; Emaldi M; Flem-Karlsen K; Mælandsmo GM; Fodstad Ø; Llarena R; López JI; Pulido R
    Front Oncol; 2022; 12():873516. PubMed ID: 35692804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the in vivo regulation of cardiac pyruvate dehydrogenase based on label flux from hyperpolarised [1-13C]pyruvate.
    Schroeder MA; Atherton HJ; Heather LC; Griffin JL; Clarke K; Radda GK; Tyler DJ
    NMR Biomed; 2011 Oct; 24(8):980-987. PubMed ID: 21387444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.
    Stacpoole PW
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic
    Cenigaonandia-Campillo A; Serna-Blasco R; Gómez-Ocabo L; Solanes-Casado S; Baños-Herraiz N; Puerto-Nevado LD; Cañas JA; Aceñero MJ; García-Foncillas J; Aguilera Ó
    Theranostics; 2021; 11(8):3595-3606. PubMed ID: 33664850
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice.
    Wu CY; Tso SC; Chuang JL; Gui WJ; Lou M; Sharma G; Khemtong C; Qi X; Wynn RM; Chuang DT
    Mol Metab; 2018 Jun; 12():12-24. PubMed ID: 29656110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.